Cigarette smoking may accelerate the progression of IgA nephropathy.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2000-
    • Subject Terms:
    • Abstract:
      Background: Whether cigarette smoking is associated with the progression of immunoglobulin A nephropathy (IgAN) remains uncertain; therefore, we aimed to evaluate the effect of cigarette smoking on the prognosis of IgAN.
      Methods: We divided 1239 IgAN patients from West China Hospital of Sichuan University who met the inclusion criteria into smoker (current or former) and non-smoker groups. The endpoint was end-stage renal disease (ESRD: eGFR < 15 mL/min/1.73 m 2 or undergoing renal replacement treatment) and/or eGFR decreased by > 50%. Kaplan-Meier, correlation, logistic regression and Cox proportional hazards analyses were performed. The association between cigarette smoking and IgAN was further verified by propensity-score-matched cohort analysis.
      Results: During the mean follow-up period of 61 months, 19% (40/209) of the smoker group and 11% (110/1030) of the non-smoker group reached the study endpoint (p < 0.001). Multivariate Cox regression analysis revealed that cigarette smoking (hazard ratio (HR) = 1.58; p = 0.043) was an independent risk factor predicting poor renal progression in IgAN, and that IgAN patients with chronic kidney disease (CKD) stage 3-4 were more susceptible to cigarette smoking (p < 0.001). After propensity score matching (PSM), a significant correlation between cigarette smoking and renal outcomes in IgAN patients was seen. Furthermore, Spearman's correlation test revealed that smoking dose was negatively correlated with eGFR (r = 0.141; p < 0.001) and positively related with proteinuria (r = 0.096; p = 0.001).
      Conclusions: Cigarette smoking is an independent risk factor for IgAN progression, especially for advanced patients.
    • References:
      APMIS. 2016 May;124(5):393-400. (PMID: 26848794)
      Hypertens Res. 2012 Mar;35(3):261-5. (PMID: 22158113)
      J Am Soc Nephrol. 2004 Aug;15(8):2178-85. (PMID: 15284303)
      Clin J Am Soc Nephrol. 2017 Apr 3;12(4):677-686. (PMID: 28159829)
      Ren Fail. 2019 Nov;41(1):914-920. (PMID: 31580172)
      Circulation. 2018 Jun 12;137(24):2572-2582. (PMID: 29661945)
      Clin J Am Soc Nephrol. 2012 Mar;7(3):427-36. (PMID: 22223610)
      Lancet. 2016 Oct 8;388(10053):1659-1724. (PMID: 27733284)
      Kidney Int. 2017 May;91(5):1014-1021. (PMID: 28341274)
      Am J Kidney Dis. 2006 Mar;47(3):396-405. (PMID: 16490617)
      Acta Diabetol. 2016 Aug;53(4):525-33. (PMID: 26668013)
      Sci Rep. 2017 Apr 24;7(1):1100. (PMID: 28439112)
      Kidney Int. 2011 Sep;80(5):516-23. (PMID: 21677635)
      Rheum Dis Clin North Am. 2018 May;44(2):203-213. (PMID: 29622292)
      Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H76-82. (PMID: 16920799)
      Nephrol Dial Transplant. 2021 Mar 29;36(4):581-586. (PMID: 31755918)
      Am J Kidney Dis. 2010 Aug;56(2):313-24. (PMID: 20471735)
      Am J Physiol Renal Physiol. 2010 Oct;299(4):F732-9. (PMID: 20685820)
    • Contributed Indexing:
      Keywords: Cigarette smoking; IgA nephropathy; Propensity score matching; Renal survival
    • Publication Date:
      Date Created: 20210630 Date Completed: 20220207 Latest Revision: 20220207
    • Publication Date:
      20240628
    • Accession Number:
      PMC8244187
    • Accession Number:
      10.1186/s12882-021-02453-4
    • Accession Number:
      34187402